Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure

被引:184
作者
Siirila-Waris, Krista
Lassus, Johan
Melin, John
Peuhkurinen, Keijo
Nieminen, Markku S.
Harjola, Veli-Pekka
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Emergency Care, Helsinki 00029, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Div Cardiol, Helsinki 00029, Finland
[3] Cent Finland Cent Hosp, Dept Med, Jyvaskyla, Finland
[4] Kuopio Univ Hosp, Dept Cardiol, SF-70210 Kuopio, Finland
关键词
acute heart failure; multicentre study; decompensated chronic heart failure; new-onset heart failure; de novo heart failure; risk markers;
D O I
10.1093/eurheartj/ehl407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Acute heart failure (AHF) is associated with poor prognosis and requires recurrent hospitalizations. However, studies on AHF characteristics, treatment, and prognostic factors are few. Our aim was to investigate the characteristics, treatment, and 1-year prognosis of AHF and identify prognostic factors in different clinical groups. Methods and results We conducted a prospective multicentre study with 620 patients hospitalized due to AHF; mean age 75.1 (10.4) years, 50% male. Half of the patients had new-onset heart failure. Acute congestion (63.5%) and pulmonary oedema (26.3%) were the most common clinical presentations. Left ventricular ejection fraction (LVEF) was reported in two- thirds of patients. Half of these had preserved systolic function (LVEF >= 45%). At discharge, 86% of patients had beta- blockers and 76% either ACE-inhibitors or angiotensin receptor blockers in use. The 12-month all-cause mortality was 27.4%. We identified several clinical and biochemical prognostic risk factors in univariate analysis. Independent predictors of 1-year mortality were older age, male gender, lower systolic blood pressure (SBP) on admission, C-reactive protein, and serum creatinine > 120 mmol/L. Conclusion We present the characteristics and prognosis of an unselected population of AHF patients. One-year mortality is high, and independent clinical risk factors include age, male gender, lower SBP on admission, C-reactive protein, and renal dysfunction.
引用
收藏
页码:3011 / 3017
页数:7
相关论文
共 22 条
  • [1] The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis
    Cleland, JGF
    Swedberg, K
    Follath, F
    Komajda, M
    Cohen-Solal, A
    Aguilar, JC
    Dietz, R
    Gavazzi, A
    Hobbs, R
    Korewicki, J
    Madeira, HC
    Moiseyev, VS
    Preda, I
    van Gilst, WH
    Widimsky, J
    Freemantle, N
    Eastaugh, J
    Mason, J
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (05) : 442 - 463
  • [2] Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction
    Dries, DL
    Sweitzer, NK
    Drazner, MH
    Stevenson, LW
    Gersh, BJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) : 421 - 428
  • [3] Anemia is common in heart failure and is associated with poor outcomes - Insights from a cohort of 12,065 patients with new-onset heart failure
    Ezekowitz, JA
    McAlister, FA
    Armstrong, PW
    [J]. CIRCULATION, 2003, 107 (02) : 223 - 225
  • [4] Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 7, pS21
  • [5] Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure
    Gustafsson, F
    Torp-Pedersen, C
    Burchardt, H
    Buch, P
    Seibaek, M
    Kjoller, E
    Gustafsson, I
    Kober, L
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (02) : 129 - 135
  • [6] Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure
    Kearney, MT
    Fox, KAA
    Lee, AJ
    Prescott, RJ
    Shah, AM
    Batin, PD
    Baig, W
    Lindsay, S
    Callahan, TS
    Shell, WE
    Eckberg, DL
    Zaman, AG
    Williams, S
    Neilson, JMM
    Nolan, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) : 1801 - 1808
  • [7] The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe Part 2: treatment
    Komajda, M
    Swedberg, K
    Cleland, J
    Aguilar, JC
    Cohen-Solal, A
    Dietz, R
    Gavazzi, A
    Van Gilst, WH
    Hobbs, R
    Madeira, HC
    Moiseyev, VS
    Preda, I
    Widimsky, J
    Freemanthle, N
    Eastaugh, J
    Mason, J
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (05) : 464 - 474
  • [8] Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure
    Lenzen, MJ
    Boersma, E
    Scholte op Reimer, WJM
    Balk, AHMM
    Komajda, M
    Swedberg, K
    Follath, F
    Jimenez-Navarro, M
    Simoons, ML
    Cleland, JGF
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (24) : 2706 - 2713
  • [9] Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure
    Logeart, D
    Thabut, G
    Jourdain, P
    Chavelas, C
    Beyne, P
    Beauvais, F
    Bouvier, E
    Solal, AC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) : 635 - 641
  • [10] Renal insufficiency and heart failure - Prognostic and therapeutic implications from a prospective cohort study
    McAlister, FA
    Ezekowitz, J
    Tonelli, M
    Armstrong, PW
    [J]. CIRCULATION, 2004, 109 (08) : 1004 - 1009